Skip to main content

Table 1 Warning signs to investigate another nephropathy

From: The 2021–2022 position of Brazilian Diabetes Society on diabetic kidney disease (DKD) management: an evidence-based guideline to clinical practice. Screening and treatment of hyperglycemia, arterial hypertension, and dyslipidemia in the patient with DKD

  1. Source: Adapted from Gross et al. [21]. ACEI Angiotensin-converting enzyme inhibitors, ARB Angiotensin receptor blockers